Osaic Holdings
SUPN icon

Osaic Holdings’s Supernus Pharmaceuticals SUPN Stock Holding History

Osaic Holdings’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.3K Buy
416
+6
+1% +$288 ﹤0.01% 6195
2026
Q1 		$21.2K Buy
410
+49
+14% +$2.5K ﹤0.01% 5816
2025
Q4 		$17.9K Sell
361
-36,579
-99% -$1.78M ﹤0.01% 5942
2025
Q3 		$1.67M Buy
36,940
+34,984
+1,789% +$1.41M ﹤0.01% 2331
2025
Q2 		$63.1K Buy
1,956
+1,328
+211% +$42.6K ﹤0.01% 4877
2025
Q1 		$20.6K Sell
628
-494
-44% -$17.5K ﹤0.01% 5351
2024
Q4 		$40.6K Sell
1,122
-7
-0.6% -$246 ﹤0.01% 4851
2024
Q3 		$35.2K Buy
1,129
+42
+4% +$1.31K ﹤0.01% 4998
2024
Q2 		$29.1K Sell
1,087
-2,188
-67% -$63.4K ﹤0.01% 5075
2024
Q1 		$112K Sell
3,275
-6,335
-66% -$189K ﹤0.01% 4168
2023
Q4 		$278K Sell
9,610
-3,208
-25% -$85.1K ﹤0.01% 3660
2023
Q3 		$353K Buy
12,818
+4,496
+54% +$137K ﹤0.01% 3542
2023
Q2 		$250K Buy
8,322
+71
+0.9% +$2.48K ﹤0.01% 3722
2023
Q1 		$299K Sell
8,251
-94
-1% -$3.61K ﹤0.01% 3559
2022
Q4 		$298K Sell
8,345
-15,495
-65% -$539K ﹤0.01% 3519
2022
Q3 		$806K Buy
23,840
+19,413
+439% +$632K ﹤0.01% 2432
2022
Q2 		$127K Buy
4,427
+169
+4% +$4.84K ﹤0.01% 4209
2022
Q1 		$138K Sell
4,258
-131
-3% -$4.02K ﹤0.01% 4331
2021
Q4 		$128K Buy
4,389
+370
+9% +$11.2K ﹤0.01% 4361
2021
Q3 		$107K Sell
4,019
-145
-3% -$3.89K ﹤0.01% 4468
2021
Q2 		$129K Buy
4,164
+169
+4% +$5.18K ﹤0.01% 4258
2021
Q1 		$104K Buy
3,995
+2,514
+170% +$70.3K ﹤0.01% 4305
2020
Q4 		$38K Sell
1,481
-2,680
-64% -$57.7K ﹤0.01% 4759
2020
Q3 		$87K Buy
4,161
+124
+3% +$2.81K ﹤0.01% 3926
2020
Q2 		$95K Buy
4,037
+529
+15% +$11.7K ﹤0.01% 3722
2020
Q1 		$63K Buy
+3,508
New +$73.7K ﹤0.01% 3806

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Osaic Holdings's SUPN Position: Q2 2026 in Review

Osaic Holdings increased its Supernus Pharmaceuticals (SUPN) stake by 1.5% in Q2 2026, buying an estimated $288 and bringing the position to 416 shares worth $19.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6195.

Osaic Holdings first reported a position in SUPN in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.67M in Q3 2025. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Osaic Holdings held 416 shares of Supernus Pharmaceuticals worth $19.3K as of Q2 2026.
  • Osaic Holdings bought 6 Supernus Pharmaceuticals shares in Q2 2026, an estimated $288.
  • Supernus Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6195 holding.
  • Osaic Holdings first reported a position in Supernus Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Supernus Pharmaceuticals position peaked at $1.67M in Q3 2025.
  • 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.